Disruption of the microbiota across multiple body sites in critically ill children

Matthew B Rogers1, Brian Firek1, Min Shi2

  • 1Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, USA.

Microbiome
|December 31, 2016
PubMed

Insights

Critically ill children in the pediatric intensive care unit (PICU) exhibit significant gut microbiome dysbiosis, with reduced diversity and altered microbial composition compared to healthy individuals. This dysbiosis may present opportunities for targeted therapeutic interventions.

Area of Science:

  • Microbiology
  • Human Health
  • Critical Care Medicine

Background:

  • The human microbiome's role in health is increasingly recognized, yet its state in pediatric intensive care unit (PICU) patients remains understudied.
  • Dysbiosis, an imbalance in microbial communities, is a potential concern for critically ill populations.

Purpose of the Study:

  • To characterize the microbial diversity and composition in children admitted to a PICU.
  • To compare the PICU microbiota with healthy adult and pediatric reference datasets.

Main Methods:

  • Analysis of bacterial 16S rRNA gene sequences from tongue, skin, and stool/rectal samples of 37 PICU children.
  • Calculation of alpha and beta diversity metrics.
  • Comparison with existing adult and pediatric microbiome data.

Main Results:

  • PICU patients showed decreased alpha diversity in gut and tongue samples compared to healthy controls.
  • Beta diversity analysis revealed distinct microbial community structures in PICU patients across body sites.
  • Enrichment of pathogens like Enterococcus and Staphylococcus, and depletion of commensals like Faecalibacterium and Ruminococcus were observed.
  • Microbiota composition was unstable over time and exhibited a loss of site specificity.
  • Dominant pathogens (>50% relative abundance) were frequently detected.

Conclusions:

  • The gut microbiota of critically ill children in the PICU is significantly altered compared to healthy children and adults.
  • Recognizing this dysbiosis offers potential avenues for precise microbiota modulation to improve patient outcomes.
Abstract